An HuR mutant, HuR-V225I, identified in adult T-cell Leukemia/Lymphoma, alters the pro-apoptotic function of HuR
2024

HuR-V225I Mutation Affects Apoptosis in Cancer Cells

publication 10 minutes Evidence: moderate

Author Information

Author(s): Colalillo Bianca, Sali Sujitha, Aldouhki Ali H., Aubry Isabelle, Di Marco Sergio, Tremblay Michel L., Gallouzi Imed E.

Primary Institution: McGill University

Hypothesis

The HuR-V225I mutation interferes with the pro-apoptotic function of HuR in cancer cells.

Conclusion

The HuR-V225I mutation reduces the efficacy of cancer therapy by preventing apoptosis in cancer cells.

Supporting Evidence

  • The HuR-V225I mutation prevents the cleavage of HuR in response to apoptotic stimuli.
  • Cells expressing HuR-V225I showed increased levels of anti-apoptotic factors like XIAP and BCL-2.
  • The mutation was identified in cancer cells, indicating its relevance to tumorigenesis.
  • HuR-V225I remains predominantly nuclear, inhibiting its pro-apoptotic function.

Takeaway

A change in a protein called HuR can help cancer cells survive longer by stopping them from dying when they should.

Methodology

The study involved transfecting cancer cells with HuR variants and assessing their response to apoptosis-inducing treatments.

Limitations

The study primarily focused on specific cancer cell lines and may not generalize to all cancer types.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/s41420-024-02268-w

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication